| Identification | Back Directory | [Name]
KPT-330, (E)-RN | [CAS]
1421923-86-5 | [Synonyms]
Kpt-330, (E)-
KPT-330, (E)-RN
Selinexor E-isomer
Selinexor trans-isomer
SELINEXOR;KPT-330; (E)-RN
(E)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide
(E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE
2-Propenoic acid, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2E)-
KPT-330, (E)-RN (E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE | [Molecular Formula]
C17H11F6N7O | [MDL Number]
MFCD28559396 | [MOL File]
1421923-86-5.mol | [Molecular Weight]
443.31 |
| Hazard Information | Back Directory | [Uses]
KPT-330 is an orally bioavailable selective?Chromosome Region Maintenance (CRM1)?inhibitor, that has been shown to block pancreatic cancer cell proliferation and reduce tumor growth in mice. |
|
|